Increased Risk of Hyperkalemia in Older Women Taking Spironolactone for Female Pattern Hair Loss

    September 2022 in “ Journal of The American Academy of Dermatology ”
    Maya Collins, Shaheir Ali, Isabel Pupo Wiss
    Studysummary This study examined the incidence of hyperkalemia in women over 65 with female pattern hair loss and spironolactone use, but the findings on risk remain unclear.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Related research 8

    1. Increased Risk of Hyperkalemia in Older Women Taking Spironolactone for Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2022
    2. The Use of Ultrasound-Targeted Microbubble Destruction Technology for Drug Delivery and Gene Transfection in the Treatment of Atherosclerosis Journal of The American Academy of Dermatology · 2020
    3. Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Hair Loss, and Hirsutism Actas Dermo-Sifiliográficas · 2020
    4. Treatment of Female Pattern Hair Loss with the Androgen Receptor Antagonist Flutamide Australasian Journal of Dermatology · 2011
    5. Lack of Effect of a Spironolactone-Containing Cream on Hair Growth in Hirsute Women Dermatology · 2009
    6. Successful Treatment of Female-Pattern Hair Loss with Spironolactone in a 9-Year-Old Girl Australasian Journal of Dermatology · 2009
    7. Treatment of Female Pattern Hair Loss with a Combination of Spironolactone and Minoxidil Australasian Journal of Dermatology · 2007
    8. Hair Loss Postgraduate Medicine · 1986